Publications in collaboration with researchers from Hospital General Universitario de Valencia (15)

2022

  1. The role of PSMA radioligands in the diagnosis and treatment of prostate carcinoma

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, Núm. 2, pp. 126-135

  2. Clinical application of [18F]FDG PET/CT in follicular lymphoma

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, Núm. 3, pp. 202-212

2020

  1. Prognostic Value and Therapeutic Implication of Laparoscopic Extraperitoneal Paraaortic Staging in Locally Advanced Cervical Cancer: A Spanish Multicenter Study

    Annals of Surgical Oncology, Vol. 27, Núm. 8, pp. 2829-2839

  2. Implications of extraperitoneal paraaortic lymphadenectomy to the left renal vein in locally advanced cervical cancer. A Spanish multicenter study

    Gynecologic Oncology, Vol. 158, Núm. 2, pp. 287-293

  3. FDG PET/CT in colorectal cancer

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 39, Núm. 1, pp. 57-66

2019

  1. Survival after biochemical failure in prostate cancer treated with radiotherapy: Spanish Registry of Prostate Cancer (RECAP) database outcomes

    Clinical and Translational Oncology, Vol. 21, Núm. 8, pp. 1044-1051

  2. Are there enough radiation oncologists to lead the new Spanish radiotherapy?

    Clinical and Translational Oncology, Vol. 21, Núm. 12, pp. 1663-1672

  3. 18F-FDG PET/CT in locally advanced cervical cancer: A review

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 38, Núm. 1, pp. 59-68

2018

  1. Radium-223 in the treatment of bone metastasis in patients with castration-resistant prostate cancer. Review and procedure

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 37, Núm. 5, pp. 330-337

  2. Infrastructure and equipment for radiation oncology in the Spanish National Health System: analysis of external beam radiotherapy 2015–2020

    Clinical and Translational Oncology, Vol. 20, Núm. 3, pp. 402-410

  3. Adjuvant versus salvage radiotherapy in prostate cancer: multi-institutional retrospective analysis of the Spanish RECAP database

    Clinical and Translational Oncology, Vol. 20, Núm. 2, pp. 193-200

2016

  1. Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272]

    Reports of Practical Oncology and Radiotherapy

2015

  1. Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance

    Reports of Practical Oncology and Radiotherapy, Vol. 20, Núm. 4, pp. 259-272

  2. Nomogramme für die Prognose eines biochemischen Rezidivs beim Prostatakarzinom nach Strahlentherapie und Androgendeprivationstherapie

    Strahlentherapie und Onkologie, Vol. 191, Núm. 10, pp. 792-800

  3. Androgen deprivation and radiotherapy in patients with prostate cancer and cardiovascular risk factors: clinical controversies

    Clinical and Translational Oncology, Vol. 17, Núm. 3, pp. 223-229